Skip to main content
Publication date
2018 01 10
Authors
Seibert, TM Fan, CC Wang, YP Zuber, V Karunamuni, R Parsons, JK Eeles, RA Easton, DF Kote-Jarai, Z Al Olama, AA Garcia, SB Muir, K Gronberg, H Wiklund, F Aly, M Schleutker, J Sipeky, C Tammela, TLJ Nordestgaard, BG Nielsen, SF Weischer, M Bisbjerg, R Roder, MA Iversen, P Key, TJ Travis, RC Neal, DE Donovan, JL Hamdy, FC Pharoah, P Pashayan, N Khaw, KT Maier, C Vogel, W Luedeke, M Herkommer, K Kibel, AS Cybulski, C Wokolorczyk, D Kluzniak, W Cannon-Albright, L Brenner, H Cuk, K Saum, KU Park, JY Sellers, TA Slavov, C Kaneva, R Mitev, V Batra, J Clements, JA Spurdle, A Teixeira, MR Paulo, P Maia, S Pandha, H Michael, A Kierzek, A Karow, DS Mills, IG Andreassen, OA Dale, AM
Group authors
PRACTICAL Consortium
Author KI Usernames
Aly, M|maraly Gronberg, H|hengro Grönberg, H|hengro Wiklund, F|frewik
Pubmed ID
29321194
Journal
BMJ (Clinical research ed.)
Doctype
Article
KI Connection
Låg
Mesh SV
Genotyp Kallikreiner Kohortstudier Manlig Medelålders personer Människa Polymorfism, enkelnukleotid Prediktivt värde av tester Prostataspecifikt antigen Prostatatumörer Resultatvärdering (Hälso- och sjukvård) Riskbedömning Sjukdomsfri överlevnad Tidig cancerupptäckt Urbefolkningen i Europa Ålder vid sjukdomsdebut Äldre Överlevnadsanalys
Mesh EN
Age of Onset Cohort Studies Disease-Free Survival Early Detection of Cancer European Continental Ancestry Group Genotype Kallikreins Outcome Assessment (Health Care) Polymorphism, Single Nucleotide Predictive Value of Tests Prostate-Specific Antigen Prostatic Neoplasms Risk Assessment Survival Analysis
First date
2018-01-29T00:01:52.521Z